Risk of Subarachnoid Hemorrhage and Early Case Fatality Associated With Outpatient Antithrombotic Drug Use
Authors:
- 1 September 2013
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 44 (9) , 2422-2426
Abstract
Background and Purpose—: Subarachnoid hemorrhage (SAH) accounts for 70 years (OR, 2.3; 95% CI, 1.8–3.1) and arterial hypertension (OR, 1.3; 95% CI, 1.0–1.6), but not with any of the antithrombotic drugs. Conclusions—: Outpatient antithrombotic drug use was associated with an increased risk of SAH, but no association was observed with early case fatality.Keywords
This publication has 21 references indexed in Scilit:
- Delayed Cerebral Ischemia After Subarachnoid HemorrhageStroke, 2013
- Platelet aggregation inhibitors, vitamin K antagonists and risk of subarachnoid hemorrhageJournal of Thrombosis and Haemostasis, 2011
- Functional outcome and quality of life 5 and 12.5 years after aneurysmal subarachnoid haemorrhageJournal of Neurology, 2010
- Prediction of 60 day case-fatality after aneurysmal subarachnoid haemorrhage: results from the International Subarachnoid Aneurysm Trial (ISAT)European Journal of Epidemiology, 2010
- Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic reviewThe Lancet Neurology, 2009
- Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trendsJournal of Neurology, Neurosurgery & Psychiatry, 2007
- Risk Factors for Subarachnoid HemorrhageStroke, 2005
- Comparative Pharmacokinetics of Vitamin K AntagonistsClinical Pharmacokinetics, 2005
- Subarachnoid HemorrhageStroke, 2002
- Prevalence and Risk of Rupture of Intracranial AneurysmsStroke, 1998